KR20040051826A - S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 - Google Patents
S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 Download PDFInfo
- Publication number
- KR20040051826A KR20040051826A KR1020020079500A KR20020079500A KR20040051826A KR 20040051826 A KR20040051826 A KR 20040051826A KR 1020020079500 A KR1020020079500 A KR 1020020079500A KR 20020079500 A KR20020079500 A KR 20020079500A KR 20040051826 A KR20040051826 A KR 20040051826A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- ibuprofen
- liquid
- kaolin
- purified water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
- 유효활성물질인 S(+)-이부프로펜 1.0∼2.0중량%, 가소제로서 농글리세린 3∼5 중량%와, 폴리옥실40경화피마자유 0.1∼0.5 중량%, 현탁화제로서 카올린, 잔탄검, 한천을 각각 0.5∼0.7 중량%, 0.05∼3.0 중량%, 0.1∼0.5 중량%, 감미제로서 백당, 씨클로덱스트린액, 디소르비톨액을 각각 60∼80 중량%, 2∼8 중량%, 2∼8 중량%를 추가로 액상과당, 아스파탐, 스테비오사이드 및 방향제, 착색제, 보존제, 용제로 구성된 pH 3.0∼9.0, 점도 500∼2,500센티포아즈를 갖는 S(+)-이부프로펜 시럽제 조성물.
- 정제수 일정량에 보존제, 백당 60∼80 중량%을 넣고 용해시킨 후, 정제수에 녹인 잔탄검 0.05∼3.0 중량%과 한천용액 0.1∼0.5 중량%을 투입하여 교반을 한다음, 다른 용기에 카올린 0.5∼0.7 중량%과 씨클로덱스트린 2∼8 중량%을 투입 교반하고, 여기에 S(+)-이부프로펜 1.0∼2.0 중량%과 액상과당, 아스파탐, 스테비오사이드를 넣고 혼합한 후 농글리세린 3∼5 중량%와 폴리옥실40경화피마자유 0.1∼0.5 중량%를 첨가하여 교반한 다음, 이 용액을 백당이 첨가된 용액에 넣고 교반한 후 착색제가 첨가된 소량의 정제수와 방향제를 넣어 제조함을 특징으로 하는 pH 3.0∼9.0 , 점도 500∼2,500센티포아즈를 갖는 S(+)이부프로펜 시럽제 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0079500A KR100509432B1 (ko) | 2002-12-13 | 2002-12-13 | S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0079500A KR100509432B1 (ko) | 2002-12-13 | 2002-12-13 | S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040051826A true KR20040051826A (ko) | 2004-06-19 |
KR100509432B1 KR100509432B1 (ko) | 2005-08-22 |
Family
ID=37345625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0079500A KR100509432B1 (ko) | 2002-12-13 | 2002-12-13 | S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100509432B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006073257A1 (en) * | 2005-01-03 | 2006-07-13 | Hanmi Pharm. Co., Ltd. | Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
JPH08333245A (ja) * | 1995-06-07 | 1996-12-17 | Taisho Pharmaceut Co Ltd | イブプロフェン懸濁液剤 |
-
2002
- 2002-12-13 KR KR10-2002-0079500A patent/KR100509432B1/ko active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006073257A1 (en) * | 2005-01-03 | 2006-07-13 | Hanmi Pharm. Co., Ltd. | Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof |
EP1845941A1 (en) * | 2005-01-03 | 2007-10-24 | Hanmi Pharm. Co., Ltd. | Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof |
JP2008526736A (ja) * | 2005-01-03 | 2008-07-24 | ハンミ ファーム. シーオー., エルティーディー. | 活性成分としてデキシブプロペンを含むシロップ剤組成物及びその製造方法 |
EP1845941A4 (en) * | 2005-01-03 | 2008-10-08 | Hanmi Pharm Ind Co Ltd | SYRUP COMPOSITION WITH DEXIBUPROPEN AS AN ACTIVE INGREDIENTS AND METHOD FOR THE PRODUCTION THEREOF |
Also Published As
Publication number | Publication date |
---|---|
KR100509432B1 (ko) | 2005-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0650354B1 (de) | Feste und flüssige lösungen von schwer wasserlöslichen arzneistoffen | |
AU2010331761B2 (en) | Composition of dexibuprofen transdermal hydrogel | |
JPH0714872B2 (ja) | シロップ剤組成物 | |
HU209436B (en) | Process for producing pharmaceutical solutions containing macrolides | |
HU196707B (en) | Process for producing pharmaceutical compositon comprising etoposide as active ingredient | |
CA2066731A1 (en) | Liquid oral pharmaceutical compositions having anti-inflammatory activity | |
IL184319A (en) | Pharmaceutical preparation of glycine-dexibropane syrup and processes for its preparation | |
TW201231048A (en) | Novel pharmaceutical formulation | |
KR100841893B1 (ko) | 프레가발린 조성물 | |
EA034565B1 (ru) | Композиции левосимендана для внутривенного введения в виде инфузии или инъекции и концентрата для инфузии | |
CA2429205C (en) | Dermatological formulations | |
EP1535916A1 (en) | Clathrates of butylphtualide with cyclodextrin or its derivatives,a process for their preparations and the use there of | |
KR20210007951A (ko) | 멜록시캄 조성물, 제제 및 이의 제조 방법 및 응용 | |
KR100509432B1 (ko) | S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 | |
EP3958852A1 (en) | Mini softgel naproxen composition | |
DE60017881T2 (de) | Trinkbare pharmazeutische suspension von ibuprofen | |
KR101297354B1 (ko) | 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물 | |
JPH0536412B2 (ko) | ||
US20210213024A1 (en) | Liquid compositions of aprepitant | |
KR20190093999A (ko) | 용해성 및 안정성이 향상된 덱시부프로펜 시럽제제 | |
KR100567131B1 (ko) | 쓴맛을 차폐한 아르기닌 함유 이부프로펜 경구투여 액상조성물 | |
JP2000247883A (ja) | ジヒドロピリジン系化合物を含有する内服用液剤 | |
KR0169402B1 (ko) | 티아졸리딘 2,4-디카르복실산 아르기닌염(아르기닌티디아시케이트)함유액제 및 그의 제조방법 | |
KR100509433B1 (ko) | S(+)-이부프로펜의 연질캅셀제 조성물 및 그의 제조방법 | |
WO2024132369A1 (en) | Pharmaceutical formulations of tafamidis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130529 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140603 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150610 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160808 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170619 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180524 Year of fee payment: 14 |